Colon cancer is a type of cancer that starts in the colon, which is part of the large intestine. It happens when the cells in the lining of the colon grow out of control and form a tumor. This cancer can spread to other parts of the body if not treated early. It often begins as small growths called polyps, which can sometimes turn into cancer over time. Regular screening can help detect and prevent colon cancer.
There are different types of colon cancer based on where it starts and the type of cells involved. Here are the main types:
Gastrointestinal Stromal Tumors (GIST)
Squamous Cell Carcinoma
Key Point
Most colon cancers are adenocarcinomas, but there are rarer types that need different treatments. Early detection through screening can help identify and treat them effectively.
Colon cancer happens when the cells in the colon (large intestine) start growing abnormally. The exact cause isn’t always known, but several factors can increase the risk.
Things You Can’t Control:
Things You Can Control:
Key Point
While some risk factors like age and genetics can’t be changed, healthy lifestyle choices like eating well, staying active, and avoiding smoking or heavy drinking can help lower the chance of colon cancer. Regular screening is also important for catching it early.
TREATMENT OF COLON CANCER
The treatment for colon cancer depends on how advanced the cancer is, where it is located, and the person’s overall health. Here are the main ways colon cancer is treated:
Pain relief, managing bowel problems, and providing emotional support.
Many people with colon cancer can be treated successfully, especially if it’s caught early. Treatment plans are often personalized, and combining different treatments can give the best results. Regular follow-ups after treatment help monitor for any signs of recurrence.
Preventing colon cancer involves making healthy lifestyle choices and staying proactive about screenings. Here are some simple steps to reduce your risk:
Key Point
Colon cancer is one of the most preventable cancers. Regular screenings, a healthy lifestyle, and knowing your family history can significantly reduce your risk. Talk to your doctor about the best prevention plan for you.
Recent advancements in colon cancer research have led to significant improvements in diagnosis, treatment, and patient outcomes. Key developments include:
KRAS-G12C Inhibitors: The U.S. Food and Drug Administration (FDA) has approved adagrasib (Krazati®) in combination with cetuximab (Erbitux®) for treating advanced colorectal cancer with the KRAS-G12C mutation. This marks the first KRAS-targeting drug approved for colorectal cancer, offering new options for patients with this specific genetic alteration.
Botensilimab and Balstilimab Combination: Clinical trials have shown that combining these two immunotherapy drugs can cause tumors to shrink or remain stable in 61% of patients with microsatellite stable metastatic colorectal cancer (MSS mCRC), a form typically resistant to other treatments. This combination has been described as “game-changing” and offers hope for patients with limited options.
Modified Salmonella Bacteria: Researchers have engineered a form of Salmonella bacteria that can target and suppress tumor cells without hindering the immune system. This approach involves modifying the bacteria to prevent depletion of asparagine, an amino acid essential for T cell function, allowing the immune system to effectively combat cancer cells. This discovery holds promise for developing bacterial therapies to fight cancer.
Precision Oncology: Advancements in genetic profiling enable treatments tailored to the individual genetic makeup of a patient’s tumor, improving the effectiveness of therapies and reducing side effects. This personalized approach allows for more targeted and efficient treatment strategies.
Liquid Biopsies: Innovative blood tests are being developed to detect circulating tumor DNA, allowing for earlier diagnosis and monitoring of colon cancer recurrence. These non-invasive tests can identify cancer-related genetic mutations in the bloodstream, facilitating timely intervention.
These advancements reflect a multidisciplinary approach to combating colon cancer, integrating targeted therapies, immunotherapy, bacterial therapy, personalized medicine, and early detection techniques to improve patient outcomes.